Likewise, the inclusion of type II diabetes patients’ experiences with GLP1-RAs was a limitation because people with type II diabetes might have a different experience with GLP1-RAs compared with patients only living with obesity. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.